NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying high-quality reagents that drive innovation in life sciences. Y-27632 dihydrochloride, a powerful and selective inhibitor of Rho-associated protein kinases (ROCK1 and ROCK2), plays a pivotal role in facilitating cutting-edge cell reprogramming and differentiation protocols. Its ability to influence cell fate and survival makes it an essential tool for researchers aiming to generate specific cell types for therapeutic applications and to deepen our understanding of developmental processes. The compound serves as a prime example of the impact of cell reprogramming agent technologies.
The process of cellular reprogramming, which involves converting mature somatic cells into induced pluripotent stem cells (iPSCs), often requires the precise modulation of multiple signaling pathways. Y-27632 dihydrochloride is frequently incorporated into these reprogramming cocktails. By inhibiting the ROCK pathway, it not only enhances the survival of the reprogrammed cells but also promotes their proliferation and maintenance in a pluripotent state. This direct influence on cell fate decisions makes it a key component in achieving efficient reprogramming, a process critical for the development of patient-specific cellular therapies and for creating advanced disease models.
Furthermore, Y-27632 dihydrochloride is instrumental in directed differentiation protocols. When scientists aim to guide stem cells towards a specific lineage, such as neural cells, cardiomyocytes, or pancreatic beta cells, the precise control of cellular environment and signaling is paramount. Y-27632 dihydrochloride, by modulating cytoskeletal organization and cell-cell interactions, can significantly improve the efficiency and purity of these differentiation processes. Its role as a selective ROCK1 ROCK2 inhibitor ensures that the desired cellular transformations occur with higher fidelity, supporting advancements in stem cell differentiation research.
The utility of Y-27632 dihydrochloride extends to its application in cryopreservation, where it acts as a cryopreservation media component. Preserving stem cells and derived cell populations is crucial for long-term storage and subsequent therapeutic use. Y-27632 dihydrochloride has been shown to improve the recovery rates and viability of cryopreserved cells, ensuring that these valuable resources remain functional after thawing. This aspect highlights its broad utility across the stem cell research workflow, from initial culture to long-term storage.
For researchers seeking to leverage these advanced cellular techniques, sourcing high-quality Y-27632 dihydrochloride is essential. NINGBO INNO PHARMCHEM CO.,LTD. provides a reliable supply of this critical reagent, supporting pioneering work in regenerative medicine and disease modeling. The compound’s consistent performance as a Rho-associated kinase inhibitor and its broad utility in achieving desired cellular outcomes underscore its significance in modern biomedical research, pushing the boundaries of what is possible with biomedical applications of small molecules.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.